Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors

Frontiers in Endocrinology(2023)10.3389/fendo.2023.951099Source: DataRank Database

Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors is a research paper published in Frontiers in Endocrinology (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.01)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Damián G. Romero ORCID,Licy L. Yanes Cardozo ORCID,Jacob E. Pruett ORCID

Live enrichment

PubMed:36875461 PMC:PMC9974663 OpenAlex:https://openalex.org/W4320922336

National Institute of General Medical Sciences

Grant: P20GM121334

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R21DK113500

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: F30DK127527

FWCI

2.01

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fendo.2023.951099/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fendo.2023.951099/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fendo.2023.951099/full

journalhttps://doi.org/10.3389/fendo.2023.951099

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36875461

Fields of Study

Ovarian function and disordersHormonal Regulation and HypertensionDiabetes Treatment and Management

MeSH Terms

Sodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, Type 2FemaleHumansHypertensionObesityPolycystic Ovary Syndrome

Keywords

Polycystic ovaryMedicineMetforminDapagliflozinInsulin resistanceEndocrinologyInternal medicineType 2 diabetesType 2 Diabetes MellitusHyperandrogenismObesityDiabetes mellitusEndocrine systemAnovulationBioinformaticsBiologyHormoneHypertensionPolycystic ovary syndrome (PCOS)Mitochondrial DysfunctionWomen’s HealthCardiometabolic ComplicationsSglt 2 Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being